- Recent Funding
- Investors
- Decheng Capital
Decheng Capital portfolio
Decheng Capital has 11 portfolio companies on record at Recent Funding, with 6 investments in the last 12 months.
About this page
It is a venture capital firm based in Silicon Valley, US, founded in 2012. It led 6 of the 13 rounds it joined. Its most recent investment on record is Phrontline Biopharma's $40M Series A round in November 2026, which it led, alongside Songqing Capital, Xiamen C&D Corporation, Oriza Holdings and 3 others. By category, its portfolio leans toward Health and bio (11) and Manufacturing and industrial (3). It has co-invested with Eclipse, Songqing Capital and Jifeng Capital, most often Eclipse (3 rounds).
About Decheng Capital
What Decheng Capital invests in
- Health and bio · 11 · 100%
- Manufacturing and industrial · 3 · 27%
- Developer tools and cloud · 1 · 9%
Decheng Capital recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A · $40M · lead | Songqing Capital, Xiamen C&D Corporation, Oriza Holdings (lead) +3 | ||
| Series A · lead | Morningside, Qianju Capital, Shunwei Capital +2 | ||
| Series B+ | Gates Frontier, Eclipse (lead), Willett Advisors LLC +6 | ||
| Series B+ · $50M · lead | Lumination Partners (lead) | ||
| Series B+ · $257M | Koch Disruptive Technologies (lead), Bristol-Myers Squibb, Eclipse +3 | ||
| Seed · $60M | Hankang Capital, Xiamen C&D Emerging Industry Equity Investment, Songqing Capital +6 | ||
| Series B+ · $45M | Yanying Investment, Grand Flight Investment, Guoke New Energy Venture Capital +6 | ||
| Series B+ · $60M · lead | Allyson Felix, Khosla Ventures, General Catalyst +5 |
How Decheng Capital invests
Decheng Capital portfolio companies
PPhrontline Biopharma$40MSeries A · Nov 2026
SSleptaySeries A · Sep 2026
CCellaresSeries B+ · Jul 2026
PPolares Medical$50MSeries B+ · Mar 2026
YYolTech Therapeutics$45MSeries B+ · Sep 2025
MMirvie$60MSeries B+ · May 2022
EEncodia$75MSeries B+ · Jan 2021
VVelosbio$58MSeries A · Oct 2018
HHaoxinqingbacker
VVintaBiobacker
AAnHeart Therapeuticsbacker
| Company | Round with Decheng Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $40M · lead | $100M | Nov 12, 2026 Series A |
Health and bio |
Series A · lead | undisclosed | Sep 28, 2026 Series A |
Health and bio |
Series B+ | $357M | Jul 16, 2026 Series B+ |
Health and bio |
Series B+ · $50M · lead | $115M | Mar 3, 2026 Series B+ |
Health and bio |
Series B+ · $45M | $45M | Sep 11, 2025 Series B+ |
Health and bio |
Series B+ · $60M · lead | $60M | May 17, 2022 Series B+ |
Health and bio |
Series B+ · $75M | $75M | Jun 26, 2024 Series A |
Health and bio |
Series A · $58M | $58M | Aug 2, 2026 Series B+ |
Health and bio |
backer | undisclosed | Sep 30, 2026 Series B+ |
Health and bio |
backer | $64M | Apr 11, 2023 round |
Health and bio |
backer | $81M | Dec 14, 2021 Series B+ |
Most frequent co-investors
EEclipse3 shared rounds · last Jul 16, 2026
- SSongqing Capital2 shared rounds · last Nov 12, 2026
JJifeng Capital2 shared rounds · last Nov 12, 2026MMed-Fine Capital2 shared rounds · last Nov 12, 2026
DDFJ Growth2 shared rounds · last Jul 16, 2026
WWillett Advisors LLC2 shared rounds · last Jul 16, 2026
88VC2 shared rounds · last Jan 28, 2026
GGV2 shared rounds · last May 17, 2022
WWellington Management2 shared rounds · last Jun 25, 2020
EEarlybird VC2 shared rounds · last Jun 25, 2020
IIDO Investments2 shared rounds · last Jun 25, 2020
EEndeavour Vision2 shared rounds · last Jun 25, 2020
Similar investors
LLightbank11 companies · 6 deals in 12 mo
PPlus Capital11 companies · 4 deals in 12 mo
BBain Capital Life Sciences11 companies · 3 deals in 12 mo
MMarshall Wace11 companies · 3 deals in 12 mo
SSixty Degree Capital11 companies · 3 deals in 12 mo
TTEN1311 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 13 rounds on Recent Funding that name Decheng Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Decheng Capital, which is a subset of its real portfolio. API: /api/v1/investors/decheng-capital (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy